Benzinga | May 13, 2021 04:32PM EDT

HTG Molecular Diagnostics Q1 EPS $(0.80) Beats $(1.02) Estimate, Sales $1.44M Miss $1.69M Estimate

HTG Molecular Diagnostics (NASDAQ:HTGM) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.02) by 21.57 percent. This is a 900 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $1.44 million which missed the analyst consensus estimate of $1.69 million by 15.09 percent. This is a 35.51 percent decrease over sales of $2.23 million the same period last year.